Statement of Organization, Functions, and Delegations of Authority, 81915-81917 [2024-23316]
Download as PDF
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Registration
The FAR Council is committed to
engaging with industry partners and the
public with regards to FAR Council
policies and issues relevant to current
and future Federal Acquisition
Regulation cases, including suggestions
and concerns with new and existing
policies. In addition, the FAR Council is
interested in hearing views on topics
such as: (1) new laws or draft legislation
on which it should focus; (2) how it can
improve the acquisition process; and (3)
how to better integrate commercial
practices into Federal acquisition. To
that end, the FAR Council is hosting a
hybrid in-person and virtual listening
session on December 4, 2024.
Industry partners and the public
wishing to attend in-person or virtually
must register. Registrants who would
like to attend in-person must do so no
later than November 15, 2024.
Registrants who would like to address
the FAR Council must register in
advance and no later than November 8,
2024. The FAR Council would like to
hear the views of as many voices as
practicable and will select questions/
comments keeping in mind the number
received, the limited time available and
the order received. Industry partners
and the public are asked to only register
to speak to one of these categories:
• New policies the FAR Council should
consider
• Existing policies the FAR Council
should amend
• Concerns/suggestions regarding rules
in process
• Concerns/suggestions regarding the
use of emerging technology
• Concerns/suggestions regarding the
process of rulemaking
• Other concerns/suggestions
To register to attend the listening
session VIRTUALLY, do so at: https://
gsa.zoomgov.com/webinar/register/
7117272728587/WN_
NU9vFABzQqmJ9mGtyUsNsQ.
To register to attend the listening
session In-Person, do so at: https://
forms.gle/yZj5RLdPdHRp5EnU8.
After registering, to request to speak
on one of the previously listed
categories, do so at: https://forms.gle/
eFLwVcdb6K4EiKSg7.
Members of the press, in addition to
registering for this event, must RSVP to
press@gsa.gov by November 8, 2024.
Format
The in-person and virtual listening
session will feature panel leaders from
the FAR Council. Please complete the
speaking request form to provide a brief
summary of your comments in a
specified category no later than 5 p.m.
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
(ET) November 8, 2024. Registered
participants that are selected to address
the FAR Council will receive a
confirmation and a timeframe to
present.
In-person FAR Council Listening
Session Panelists will be:
Jeffrey A. Koses, Senior Procurement
Executive, General Services
Administration
John M. Tenaglia, Principal Director,
Defense Pricing, Contracting, and
Acquisition Policy, Office of the
Secretary of Defense, Department of
Defense
Karla S. Jackson, Assistant
Administrator for Procurement,
NASA Headquarters
Agenda
• 9:00: Welcome and Introduction of
the FAR Council
• 9:15: Facilitated opportunities for
attendees to engage with the FAR
Council
• 11:45: Closing remarks by FAR
Council
Special Accommodations
This virtual meeting is accessible to
people with disabilities using the Zoom
close captioned feature.
Frederick Landry,
Analyst, Office of the Procurement
Ombudsman, General Services
Administration.
[FR Doc. 2024–23343 Filed 10–8–24; 8:45 am]
BILLING CODE 6820–61–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Statement of Organization, Functions,
and Delegations of Authority
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
AGENCY:
The Agency for Healthcare
Research and Quality has modified its
organizational structure.
SUPPLEMENTARY INFORMATION: Part E,
chapter E (Agency for Healthcare
Research and Quality), of the Statement
of Organization, Functions, and
Delegations of Authority for the
Department of Health and Human
Services (61 FR 15955–58) April 10,
1996, most recently amended at 81 FR
22271 on April 15, 2016) is amended to
reflect recent organizational changes.
The specific amendments are as follows:
SUMMARY:
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
81915
I. Under Section E–10, Organization,
delete all components and replace them
with the following:
A. Office of the Director.
B. Center for Evidence and Practice
Improvement.
C. Center for Quality Improvement and
Patient Safety.
D. Center for Financing, Access, and
Cost Trends.
E. Office of Communications.
F. Office of Extramural Research,
Education, and Priority Populations.
G. Office of Management Services.
II. Under Section E–20, Functions,
delete Center for Evidence and Practice
Improvement, Center for Financing,
Access, and Cost Trends, Center for
Quality Improvement and Patient
Safety, and Office of the Director in its
entirety and replace with the following:
Center for Evidence and Practice
Improvement. Conducts and supports
research on health care delivery and
practice improvement across the
continuum of care from prevention to
chronic care management to end-of-life
care. Specifically: (1) Synthesizes
evidence and translates science for
multiple stakeholders; (2) advances
decision and communication sciences to
facilitate informed treatment and
healthcare decision-making by patients
and their healthcare providers; (3)
explores how digital healthcare research
can improve clinical decision-making
and health care quality; (4) catalyzes
and promotes sustainability of
improvements in clinical practice across
health care settings through research,
demonstration projects, and partnership
development; (5) studies the roles that
health professionals, health systems,
and organizations play in the provision
of health care services; (6) examines the
role of health systems in improving
quality and efficiency of health care
services; and (7) operates the National
Center for Excellence in Primary Care
Research.
Shall be organized into the following
four divisions:
Division of Evidence-Based Practice
Centers: Produces evidence syntheses
by conducting systematic evidence
reviews using robust and rigorous
methodologies and advances evidence
synthesis methods to ensure scientific
rigor and unbiased reviews.
Division of U.S. Preventive Services
Task Force: Provides scientific,
administrative, and dissemination
support for the independent U.S.
Preventive Services Task Force,
enabling the Task Force to make
evidence-based recommendations on
clinical preventive services.
Division of Digital Healthcare
Research: Utilizes advanced analytics to
E:\FR\FM\09OCN1.SGM
09OCN1
khammond on DSKJM1Z7X2PROD with NOTICES
81916
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
enhance healthcare decision-making
and research how facets of the evolving
digital healthcare ecosystem can best
create transformational value for
patients and their families in delivering
safe and effective care.
Division of Practice Improvement:
Advances the science of clinical
practice improvement, including shared
decision-making; evaluates and
supports innovative models of practice
transformation in diverse settings;
facilitates communities of learning to
promote the implementation of
evidence for practice improvement; and
serves as a trusted source of evidence
and tool development for methods,
measures, and evaluation of practice
improvement.
Center for Financing, Access, and
Cost Trends. Conducts and supports
studies of the use of and expenditures
for healthcare services, the sources of
payment for that care, the availability
and cost of health insurance, and access
to healthcare. Administers large-scale
surveys and develops large data sets to
support health care policy and
behavioral research and analysis.
Shall be organized into the following
four divisions:
Division of Statistical Research and
Methods (DSRM): Provides a wide range
of statistical activities for designing and
implementing the Medical Expenditure
Panel Survey (MEPS) and for planning
and researching to help guide and
improve these data collection and
analysis.
Division of Research and Modeling
(DRM): Conducts studies on access to,
costs, and financing of healthcare
services. Provides ongoing analytic
support to MEPS design and
implementation. Develops and
maintains various simulation models,
components, databases, tools, and
research products that enhance the
value of the AHRQ data. Utilizes these
models and databases to conduct
microsimulation analyses of the effects,
on households and individuals, of
health policies embodied in current law
and the potential impacts of healthcare
policies embodied in generic versions of
proposed healthcare reforms.
Division of Survey Operations (DSO):
Oversees the MEPS data collection,
processing, and distribution activities.
Directs data collection for the major
MEPS surveys, prepares data files for
public use, and conducts workshops on
the appropriate use of MEPS data.
Publishes statistical briefs, research
findings, and a series of methodological
reports. Manages a data center for
researchers that houses MEPS data and
maintains liaisons with Federal and
non-federal individuals and
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
organizations engaged in health services
research.
Division of Healthcare Delivery and
Systems Research (DHDSR): Develops
new evidence, tools, and measures to
understand how health care is delivered
in the U.S., emphasizing the roles that
physicians, physician practices,
hospitals, health systems, other medical
professionals, and organizations play in
the provision of health care services.
Center for Quality Improvement and
Patient Safety. Measures the
performance of the U.S. health care
system; identifies, promotes, and
supports evidence-based research; and
provides information used to improve
the safety and quality of health care.
Collaborates with stakeholders across
the health care system to implement
evidence-based practices and accelerate
and amplify improvements in quality,
including patient and workforce safety.
Shall be organized into the following
five divisions:
Division of General Patient Safety:
Leads research efforts on the risks and
harms inherent in delivering healthcare
services in various settings. Develops,
tests, and facilitates understanding and
use of evidence-based tools and
information to improve the quality and
safety of health care and reduce the risk
of patient harm.
Division of Patient Safety
Organizations: Administers the Patient
Safety Organization (PSO) Program per
the Patient Safety and Quality
Improvement Act 2005. Approves and
oversees PSOs that apply for official
federal ‘‘listing.’’ Publishes Common
Formats for measuring adverse events in
hospitals.
Division of Healthcare-Associated
Infections: Leads research studies and
implementation projects that prevent,
reduce, and ultimately eliminate
healthcare-associated infections (HAIs)
and combat antibiotic resistance. It
fosters the creation of new knowledge
and the generation of evidence to
develop improved methods for
preventing healthcare-associated
infections and improving antibiotic use
in multiple settings. It promotes the
wide-scale implementation of effective
interventions for preventing HAIs and
promoting antibiotic stewardship in all
these care settings.
Division of Quality Measurement and
Improvement: Conducts quality
measurement and evaluates
improvement activities to improve
healthcare delivered in the United
States. Seeks opportunities to integrate
various measurement efforts to provide
a complete picture of quality and safety.
Promotes enhanced collaboration and
coordination of measurement efforts,
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
including integration where possible, to
serve the needs of multiple stakeholders
who use measurements, such as frontline clinicians, patients, safety and
quality experts, administrators,
researchers, payers, policymakers, and
others. Conducts focused measurement
programs, including the Consumer
Assessment of Healthcare Providers and
Systems, Surveys on Patient Safety
Culture programs, and the AHRQ
Quality Indicators.
Division of Healthcare Data and
Analytics (DHDA): Leads the
development, production, and
improvement of healthcare delivery data
and tools for use in research and policy
analysis focused on HCUP and the
supply side of the medical care market.
Directs, conducts, and supports research
on health care delivery and utilization
to examine issues related to access,
utilization, cost, safety, and quality of
hospital, physician, and other services.
Disseminates data, tools, and statistics
to facilitate and inform public and
private health policy analysis, clinical
studies, and socioeconomic research.
Office of the Director (OD). Provides
leadership of the Agency and is
responsible for planning, managing, and
coordinating Agency programs and
activities in fulfillment of AHRQ’s
mission. Principal activities include
ensuring the overall scientific integrity
and objectivity of the Agency’s research
and programs; directing and
coordinating the Agency’s programs,
research, training programs, and
dissemination activities; ensuring
Agency programs support
Administration goals and objectives;
representing the Agency within the
Department, at the highest levels of
Government, and to the public.
Shall be organized into the following
two sub-offices:
Immediate Office of the Director
(IOD). Provides overall leadership of the
Agency and plans, manages, and
coordinates the programs and activities
of all AHRQ components. The IOD
supports the Director and Deputy
Director in achieving the Agency’s
mission. Specifically, (1) provides
strategic advice to the Director in
support of agency priorities; (2)
coordinates the legislative activities of
the Agency; (3) manages the day-to-day
operations of the Office of the Director
and provides administrative support
services; and (4) controls the flow of
correspondence and official documents
entering and leaving the Agency.
Office of Policy, Planning, and
Evaluation. Directs and coordinates
AHRQ’s policy, planning, and
evaluation. Specifically, (1) directs and
coordinates program planning activities
E:\FR\FM\09OCN1.SGM
09OCN1
Federal Register / Vol. 89, No. 196 / Wednesday, October 9, 2024 / Notices
in fulfillment of the Agency’s mission;
(2) plans and manages the program
evaluation activities of the Agency,
including evaluations of dissemination,
training, and research programs; (3)
provides support and management for
the activities of the Agency’s National
Advisory Council; and (4) maintains
ongoing liaison with public and private
sector producers and users of health
services research.
All delegations and redelegations of
authority to officers and employees of
the Agency for Healthcare Research and
Quality officers and employees
immediately before the effective date of
this reorganization shall continue in
effect pending further redelegation,
provided they are consistent with this
reorganization.
These changes are effective upon the
date of signature.
Dated: October 3, 2024.
Robert Otto Valdez,
Director.
[FR Doc. 2024–23316 Filed 10–8–24; 8:45 am]
BILLING CODE 4160–90–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifiers: CMS–10142 and
CMS–10203]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
FOR FURTHER INFORMATION CONTACT:
Centers for Medicare &
Medicaid Services, Health and Human
Services (HHS).
ACTION: Notice.
Contents
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), Federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information (including each proposed
extension or reinstatement of an existing
collection of information) and to allow
60 days for public comment on the
proposed action. Interested persons are
invited to send comments regarding our
burden estimates or any other aspect of
this collection of information, including
the necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions,
the accuracy of the estimated burden,
ways to enhance the quality, utility, and
clarity of the information to be
This notice sets out a summary of the
use and burden associated with the
following information collections. More
detailed information can be found in
each collection’s supporting statement
and associated materials (see
ADDRESSES).
CMS–10142 Bid Pricing Tool (BPT) for
Medicare Advantage (MA) Plans and
Prescription Drug Plans (PDP)
CMS–10203 Medicare Health Outcomes
Survey
Under the PRA (44 U.S.C. 3501–
3520), Federal agencies must obtain
approval from the Office of Management
and Budget (OMB) for each collection of
information they conduct or sponsor.
The term ‘‘collection of information’’ is
defined in 44 U.S.C. 3502(3) and 5 CFR
1320.3(c) and includes agency requests
or requirements that members of the
public submit reports, keep records, or
provide information to a third party.
AGENCY:
SUMMARY:
khammond on DSKJM1Z7X2PROD with NOTICES
collected, and the use of automated
collection techniques or other forms of
information technology to minimize the
information collection burden.
DATES: Comments must be received by
December 9, 2024.
ADDRESSES: When commenting, please
reference the document identifier or
OMB control number. To be assured
consideration, comments and
recommendations must be submitted in
any one of the following ways:
1. Electronically. You may send your
comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) that are accepting
comments.
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number: lll, Room C4–26–
05, 7500 Security Boulevard, Baltimore,
Maryland 21244–1850.
To obtain copies of a supporting
statement and any related forms for the
proposed collection(s) summarized in
this notice, please access the CMS PRA
website by copying and pasting the
following web address into your web
browser: https://www.cms.gov/
Regulations-and-Guidance/Legislation/
PaperworkReductionActof1995/PRAListing.
VerDate Sep<11>2014
17:05 Oct 08, 2024
Jkt 265001
William N. Parham at (410) 786–4669.
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
81917
Section 3506(c)(2)(A) of the PRA
requires Federal agencies to publish a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, before
submitting the collection to OMB for
approval. To comply with this
requirement, CMS is publishing this
notice.
Information Collections
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA)
Plans and Prescription Drug Plans
(PDP); Use: Medicare Advantage
organizations (MAO) and Prescription
Drug Plans (PDP) are required to submit
an actuarial pricing ‘‘bid’’ for each plan
offered to Medicare beneficiaries for
approval by CMS. The MAOs and PDPs
use the Bid Pricing Tool (BPT) software
to develop their actuarial pricing bid.
The competitive bidding process
defined by the ‘‘The Medicare
Prescription Drug, Improvement, and
Modernization Act’’ (MMA) applies to
both the MA and Part D programs. It is
an annual process that encompasses the
release of the MA rate book in April, the
bid’s that plans submit to CMS in June,
and the release of the Part D and RPPO
benchmarks, which typically occurs in
August. Form Number: CMS–10142
(OMB control number: 0938–0944);
Frequency: Yearly; Affected Public:
Private sector—Business or other forprofit and Not-for-profit institutions;
Number of Respondents: 460; Total
Annual Responses: 11,700; Total
Annual Hours: 406,000. (For policy
questions regarding this collection
contact Rachel Shevland at 410–786–
3026 or rachel.shevland@cms.hhs.gov.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare Health
Outcomes Survey; Use: The HOS is a
longitudinal patient-reported outcome
measure (PROM) that assesses selfreported beneficiary quality of life and
daily functioning. As a PROM, the HOS
measures the impact of services
provided by MAOs, whereas process
and patient experience measures only
provide a snapshot of activities or
experiences at a specific point in time.
PROM data collected by the HOS allows
CMS to continue to assess the health of
the Medicare Advantage population.
This older population is at increased
risk of adverse health outcomes,
including chronic diseases and mobility
impairments that may significantly
E:\FR\FM\09OCN1.SGM
09OCN1
Agencies
[Federal Register Volume 89, Number 196 (Wednesday, October 9, 2024)]
[Notices]
[Pages 81915-81917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-23316]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Statement of Organization, Functions, and Delegations of
Authority
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Agency for Healthcare Research and Quality has modified
its organizational structure.
SUPPLEMENTARY INFORMATION: Part E, chapter E (Agency for Healthcare
Research and Quality), of the Statement of Organization, Functions, and
Delegations of Authority for the Department of Health and Human
Services (61 FR 15955-58) April 10, 1996, most recently amended at 81
FR 22271 on April 15, 2016) is amended to reflect recent organizational
changes. The specific amendments are as follows:
I. Under Section E-10, Organization, delete all components and
replace them with the following:
A. Office of the Director.
B. Center for Evidence and Practice Improvement.
C. Center for Quality Improvement and Patient Safety.
D. Center for Financing, Access, and Cost Trends.
E. Office of Communications.
F. Office of Extramural Research, Education, and Priority Populations.
G. Office of Management Services.
II. Under Section E-20, Functions, delete Center for Evidence and
Practice Improvement, Center for Financing, Access, and Cost Trends,
Center for Quality Improvement and Patient Safety, and Office of the
Director in its entirety and replace with the following:
Center for Evidence and Practice Improvement. Conducts and supports
research on health care delivery and practice improvement across the
continuum of care from prevention to chronic care management to end-of-
life care. Specifically: (1) Synthesizes evidence and translates
science for multiple stakeholders; (2) advances decision and
communication sciences to facilitate informed treatment and healthcare
decision-making by patients and their healthcare providers; (3)
explores how digital healthcare research can improve clinical decision-
making and health care quality; (4) catalyzes and promotes
sustainability of improvements in clinical practice across health care
settings through research, demonstration projects, and partnership
development; (5) studies the roles that health professionals, health
systems, and organizations play in the provision of health care
services; (6) examines the role of health systems in improving quality
and efficiency of health care services; and (7) operates the National
Center for Excellence in Primary Care Research.
Shall be organized into the following four divisions:
Division of Evidence-Based Practice Centers: Produces evidence
syntheses by conducting systematic evidence reviews using robust and
rigorous methodologies and advances evidence synthesis methods to
ensure scientific rigor and unbiased reviews.
Division of U.S. Preventive Services Task Force: Provides
scientific, administrative, and dissemination support for the
independent U.S. Preventive Services Task Force, enabling the Task
Force to make evidence-based recommendations on clinical preventive
services.
Division of Digital Healthcare Research: Utilizes advanced
analytics to
[[Page 81916]]
enhance healthcare decision-making and research how facets of the
evolving digital healthcare ecosystem can best create transformational
value for patients and their families in delivering safe and effective
care.
Division of Practice Improvement: Advances the science of clinical
practice improvement, including shared decision-making; evaluates and
supports innovative models of practice transformation in diverse
settings; facilitates communities of learning to promote the
implementation of evidence for practice improvement; and serves as a
trusted source of evidence and tool development for methods, measures,
and evaluation of practice improvement.
Center for Financing, Access, and Cost Trends. Conducts and
supports studies of the use of and expenditures for healthcare
services, the sources of payment for that care, the availability and
cost of health insurance, and access to healthcare. Administers large-
scale surveys and develops large data sets to support health care
policy and behavioral research and analysis.
Shall be organized into the following four divisions:
Division of Statistical Research and Methods (DSRM): Provides a
wide range of statistical activities for designing and implementing the
Medical Expenditure Panel Survey (MEPS) and for planning and
researching to help guide and improve these data collection and
analysis.
Division of Research and Modeling (DRM): Conducts studies on access
to, costs, and financing of healthcare services. Provides ongoing
analytic support to MEPS design and implementation. Develops and
maintains various simulation models, components, databases, tools, and
research products that enhance the value of the AHRQ data. Utilizes
these models and databases to conduct microsimulation analyses of the
effects, on households and individuals, of health policies embodied in
current law and the potential impacts of healthcare policies embodied
in generic versions of proposed healthcare reforms.
Division of Survey Operations (DSO): Oversees the MEPS data
collection, processing, and distribution activities. Directs data
collection for the major MEPS surveys, prepares data files for public
use, and conducts workshops on the appropriate use of MEPS data.
Publishes statistical briefs, research findings, and a series of
methodological reports. Manages a data center for researchers that
houses MEPS data and maintains liaisons with Federal and non-federal
individuals and organizations engaged in health services research.
Division of Healthcare Delivery and Systems Research (DHDSR):
Develops new evidence, tools, and measures to understand how health
care is delivered in the U.S., emphasizing the roles that physicians,
physician practices, hospitals, health systems, other medical
professionals, and organizations play in the provision of health care
services.
Center for Quality Improvement and Patient Safety. Measures the
performance of the U.S. health care system; identifies, promotes, and
supports evidence-based research; and provides information used to
improve the safety and quality of health care. Collaborates with
stakeholders across the health care system to implement evidence-based
practices and accelerate and amplify improvements in quality, including
patient and workforce safety.
Shall be organized into the following five divisions:
Division of General Patient Safety: Leads research efforts on the
risks and harms inherent in delivering healthcare services in various
settings. Develops, tests, and facilitates understanding and use of
evidence-based tools and information to improve the quality and safety
of health care and reduce the risk of patient harm.
Division of Patient Safety Organizations: Administers the Patient
Safety Organization (PSO) Program per the Patient Safety and Quality
Improvement Act 2005. Approves and oversees PSOs that apply for
official federal ``listing.'' Publishes Common Formats for measuring
adverse events in hospitals.
Division of Healthcare-Associated Infections: Leads research
studies and implementation projects that prevent, reduce, and
ultimately eliminate healthcare-associated infections (HAIs) and combat
antibiotic resistance. It fosters the creation of new knowledge and the
generation of evidence to develop improved methods for preventing
healthcare-associated infections and improving antibiotic use in
multiple settings. It promotes the wide-scale implementation of
effective interventions for preventing HAIs and promoting antibiotic
stewardship in all these care settings.
Division of Quality Measurement and Improvement: Conducts quality
measurement and evaluates improvement activities to improve healthcare
delivered in the United States. Seeks opportunities to integrate
various measurement efforts to provide a complete picture of quality
and safety. Promotes enhanced collaboration and coordination of
measurement efforts, including integration where possible, to serve the
needs of multiple stakeholders who use measurements, such as front-line
clinicians, patients, safety and quality experts, administrators,
researchers, payers, policymakers, and others. Conducts focused
measurement programs, including the Consumer Assessment of Healthcare
Providers and Systems, Surveys on Patient Safety Culture programs, and
the AHRQ Quality Indicators.
Division of Healthcare Data and Analytics (DHDA): Leads the
development, production, and improvement of healthcare delivery data
and tools for use in research and policy analysis focused on HCUP and
the supply side of the medical care market. Directs, conducts, and
supports research on health care delivery and utilization to examine
issues related to access, utilization, cost, safety, and quality of
hospital, physician, and other services. Disseminates data, tools, and
statistics to facilitate and inform public and private health policy
analysis, clinical studies, and socioeconomic research.
Office of the Director (OD). Provides leadership of the Agency and
is responsible for planning, managing, and coordinating Agency programs
and activities in fulfillment of AHRQ's mission. Principal activities
include ensuring the overall scientific integrity and objectivity of
the Agency's research and programs; directing and coordinating the
Agency's programs, research, training programs, and dissemination
activities; ensuring Agency programs support Administration goals and
objectives; representing the Agency within the Department, at the
highest levels of Government, and to the public.
Shall be organized into the following two sub-offices:
Immediate Office of the Director (IOD). Provides overall leadership
of the Agency and plans, manages, and coordinates the programs and
activities of all AHRQ components. The IOD supports the Director and
Deputy Director in achieving the Agency's mission. Specifically, (1)
provides strategic advice to the Director in support of agency
priorities; (2) coordinates the legislative activities of the Agency;
(3) manages the day-to-day operations of the Office of the Director and
provides administrative support services; and (4) controls the flow of
correspondence and official documents entering and leaving the Agency.
Office of Policy, Planning, and Evaluation. Directs and coordinates
AHRQ's policy, planning, and evaluation. Specifically, (1) directs and
coordinates program planning activities
[[Page 81917]]
in fulfillment of the Agency's mission; (2) plans and manages the
program evaluation activities of the Agency, including evaluations of
dissemination, training, and research programs; (3) provides support
and management for the activities of the Agency's National Advisory
Council; and (4) maintains ongoing liaison with public and private
sector producers and users of health services research.
All delegations and redelegations of authority to officers and
employees of the Agency for Healthcare Research and Quality officers
and employees immediately before the effective date of this
reorganization shall continue in effect pending further redelegation,
provided they are consistent with this reorganization.
These changes are effective upon the date of signature.
Dated: October 3, 2024.
Robert Otto Valdez,
Director.
[FR Doc. 2024-23316 Filed 10-8-24; 8:45 am]
BILLING CODE 4160-90-P